Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 Variant
- 10 March 2016
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (8) , e61-e67
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancerBreast Cancer Research and Treatment, 2011
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingProceedings of the National Academy of Sciences, 2011
- A PALB2 mutation associated with high risk of breast cancerBreast Cancer Research, 2010
- Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic CancerGastroenterology, 2009
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility GeneScience, 2009
- Penetrance Analysis of the PALB2 c.1592delT Founder MutationClinical Cancer Research, 2008
- Genetic subtyping of Fanconi anemia by comprehensive mutation screeningHuman Mutation, 2007
- Fanconi anemia is associated with a defect in the BRCA2 partner PALB2Nature Genetics, 2006
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancerNature Genetics, 2006